CDH3, a plasma membrane protein, is involved in cell adhesion and has been proposed as a tissue marker in human BRCA1-deficient breast cancer as well as a serum marker in basal-like breast cancer [14, 15]. This evidence concerns the gene CDH3 and breast cancer.